KR0130886B1 - Process for preparing fluoro quinoline derivatives - Google Patents

Process for preparing fluoro quinoline derivatives

Info

Publication number
KR0130886B1
KR0130886B1 KR1019930000891A KR930000891A KR0130886B1 KR 0130886 B1 KR0130886 B1 KR 0130886B1 KR 1019930000891 A KR1019930000891 A KR 1019930000891A KR 930000891 A KR930000891 A KR 930000891A KR 0130886 B1 KR0130886 B1 KR 0130886B1
Authority
KR
South Korea
Prior art keywords
formula
compound
alumina
reaction
fluoro
Prior art date
Application number
KR1019930000891A
Other languages
Korean (ko)
Other versions
KR940018378A (en
Inventor
김완주
이태석
남근수
김봉진
하재두
박영원
Original Assignee
채영복
재단법인한국화학연구소
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 채영복, 재단법인한국화학연구소 filed Critical 채영복
Priority to KR1019930000891A priority Critical patent/KR0130886B1/en
Publication of KR940018378A publication Critical patent/KR940018378A/en
Application granted granted Critical
Publication of KR0130886B1 publication Critical patent/KR0130886B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

본 발명은 다음 구도식(Ⅰ)의 플루오로 퀴놀린 유도체의 새로운 제조방법과 그의 약제학으로 허용가능한 염의 제조방법인 것이다.The present invention is a novel method for preparing the fluoro quinoline derivative of the following formula (I) and a method for preparing a pharmaceutically acceptable salt thereof.

윗 식에서, R3는 수소 또는 메틸 에틸기 또는 탄소수 3개 이하의 저급알킬기이다.In the above formula, R 3 is hydrogen or methyl ethyl group or lower alkyl group having 3 or less carbon atoms.

Description

[발명의 명칭][Name of invention]

플루오로 퀴놀론 유도체의 제조방법Method for preparing fluoroquinolone derivatives

[발명의 상세한 설명]Detailed description of the invention

본 발명은 다음 구조식 (Ⅰ)로 표시되는 플루오로 퀴놀린 유도체의 제조방법에 관한 것이다.The present invention relates to a method for producing a fluoro quinoline derivative represented by the following structural formula (I).

윗 식에서, R3는 수소, 메틸기, 에틸기 또는 탄소수 3개 이하의 저급 알킬기이다.In the above formula, R 3 is hydrogen, methyl group, ethyl group or lower alkyl group having 3 or less carbon atoms.

상기 구조식(Ⅰ)의 화합물을 제조함에 있어서 유용한 원료물질은 1-시클로프로필-7-클로로-6-플루오로-1,4-디히드로-4-옥소퀴놀린-3-카르복실산 또는 1-시클로프로필-6,7-디플루오로-1,4-디히드로-4-옥소퀴놀린-3-카르복실산 화합물을 제조하는 방법은 유럽특허 제133,093호, 제117,473호, 독일특허 제3,142,854호, 한국공개 특허공보 제83-7642호, 제84-6989호, 제84-6990호, 제84-7877호, 제85-4962호 등에 기재되어 있다.Useful raw materials for preparing the compound of formula (I) are 1-cyclopropyl-7-chloro-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid or 1-cyclo Methods for preparing propyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid compound are described in European Patent Nos. 133,093, 117,473, German Patent No. 3,142,854, Korea Published Patent Publication Nos. 83-7642, 84-6989, 84-6990, 84-7877, 85-4962 and the like.

상기 특허에 기재된 방법에서는 2,4-디클로로-5-플루오로 안식향산을 출발물질로 하고 있는데, 이 방법은 상기 출발물질을 합성하기 위하여 불화수소를 사용하여야 하므로 특수한 장치가 필요하고, 공정이 길며, 수율이 낮은 단점을 갖고 있다.In the method described in the patent, 2,4-dichloro-5-fluoro benzoic acid is used as a starting material. Since this method requires the use of hydrogen fluoride to synthesize the starting material, a special apparatus is required, and the process is long, It has the disadvantage of low yield.

한편, 1-시클로프로필-6-플루오로-7-피레라지닐-1,4-디히드로-4-옥소퀴놀린-3-카르복실산(시프로플록사신)을 제조하고 방법으로는 유럽특허 제3142856호, 일본특허 제64-40460호, 제61-36265호(이상 Bayer A.G.)와 미국특허 제4,833,270호(American Cyanamid. Co), 일본특허 제60-72885호, 제63-45261호, 한국 특허출원 제87-1893호, J.Org.Chem., 55,773, J.Med.Chem., 34, 168(이상 Warner -Lambert Co), ES 제548,375호, ES 제540,226호, ES 제542,441호, 제132,845호 유럽특허 제287,951호 이외에 한국 특허출원 제87-1190호(중외제약), 제85-4962호(동아제약), 제91-3634호, 제91-3630호, 제90-1079호, 제90-1078호, 제90-2054호(이상 KIST), 한국공개특허공보 제90-2041호(제일제당), ES 제2,006,977호, ES 제2,015,442호(이상 Union Quimico Farm. S.A.)등에 기술되어 있다.Meanwhile, 1-cyclopropyl-6-fluoro-7-pyrerazinyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid (ciprofloxacin) is prepared and described in European Patent No. 3314856, Japanese Patent Nos. 64-40460, 61-36265 (above Bayer AG) and US Patent 4,833,270 (American Cyanamid. Co), Japanese Patent Nos. 60-72885, 63-45261, and Korean Patent Application No. 87 -1893, J. Org. Chem., 55, 773, J. Med. Chem., 34, 168 (above Warner-Lambert Co), ES 548,375, ES 540,226, ES 542,441, 132,845 Europe In addition to patents 287,951, Korean Patent Application Nos. 87-1190 (Sino-Foreign Pharmaceuticals), 85-4962 (Dong-A Pharmaceutical), 91-3634, 91-3630, 90-1079, 90-1078 No. 90-2054 (hereinafter referred to as KIST), Korean Patent Publication No. 90-2041 (JeongJuang), ES 2,006,977, ES 2,015,442 (hereinafter Union Quimico Farm. SA), and the like.

Bayer A.G.에서 개발된 제조방법은 시프로플록사신뿐 만 아니라, 여러중류의 퀴놀론계 항균제의 제조에 이용되는 가장 일반적 방법으로서, 2,4-디클로로-5-플루오로 안산향산을 출발물질로 하여 4 내지 7단계에 걸쳐 제조하는 방법이다. 이 방법은 수율상에 있어서는 비교적 좋은 편이나 제조공정이 길고 값비싼 출발물질을 사용하는 단점이 있다.The manufacturing method developed by Bayer AG is the most common method used to prepare not only ciprofloxacin, but also various kinds of quinolone antibacterial agents. It is a 4 to 7 step using 2,4-dichloro-5-fluoro anacid as a starting material. It is a method to manufacture over. This method is relatively good in yield but has the disadvantage of using a long and expensive starting material.

American Cyanamid Co.의 제조방법은 출발물질로서 값비싼 2-아미노-4,5-디플루오로 안산향산을 사용하여 Bayer A.G.사와 동일한 제조 과정을 거치는데 제조공정이 길고 수율이 낮은 단점을 가지고 있다.American Cyanamid Co.'s manufacturing process uses expensive 2-amino-4,5-difluoro anhydrous acid as the starting material, and has the same manufacturing process as Bayer A.G., which has a long manufacturing process and low yield.

Warner-Lambert의 제조방법은 출발물질로서 2,4,5-트리플루오로-1-브로모벤젠을 사용하고 카르복실산 그룹을 도입하여 2,4,5-트리플루오로 안식향산을 제조한 후, 7단계의 공정과정을 거치는데 상기 방법 또한 공정 단계가 길고 수율이 낮은 단점이 있다.Warner-Lambert is prepared by using 2,4,5-trifluoro-1-bromobenzene as a starting material and introducing a carboxylic acid group to prepare 2,4,5-trifluoro benzoic acid, The process also has a seven-step process, the process has a long process steps and low yields.

ES 548,375호 및 ES 제540,226호 특허에 의한 방법은 N-1위치에 시클로프로 필브로마이드를 이용, 포타슘카보네이트 등의 염기를 사용하여 시클로프로필을 도입하는 방법으로 수율이 매우 낮으며 고가의 시클로프로필브로마이드를 사용하는 단점을 가지고 있으며, 한국 특허공보 제87-1190호(중외제약)에 의한 방법은 제조방법이 6단계의 공정을 거치지만 기존의 방법과 동일한 단점을 가지고 있다.The method described in ES 548,375 and ES 540,226 is a method in which cyclopropyl is introduced using a base such as potassium carbonate using cyclopropyl bromide at the N-1 position, and the yield is very low and expensive cyclopropyl bromide is introduced. The method according to Korean Patent Publication No. 87-1190 (Sino-Pharmaceuticals) has the same disadvantages as the existing method although the manufacturing method is a six-step process.

한국 공개특허공보 제90-2041호(제일제당)의 경우 모핵과 피페라진과의 축합반응시 값비싼 상전이 촉매를 사용하는 단점이 있다.Korean Patent Publication No. 90-2041 (Cheil Jedang) has the disadvantage of using an expensive phase transfer catalyst in the condensation reaction between the parent nucleus and the piperazine.

이에 본 발명은 종래의 방법과는 달리 간편하며, 제조공정단계가 짧고, 경제적이며, 높은 수득률로 플루오로 퀴놀린 유도체를 제조하는 방법을 제공하는데 그 목적이 있다.Accordingly, the present invention provides a method for preparing a fluoroquinoline derivative with a simple, economical, high yield, unlike the conventional method, and a short manufacturing process step.

이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.

본 발명은 다음 구조식Z(Ⅱ)의 화합물을 포밀화하여 다음 구조식(Ⅲ)의 화합물을 제조하는 단계와, 상기에서 얻어진 다음 구조식(Ⅲ)의 화합물을 다음 구조식(Ⅳ)의 화합물과 반응시켜서 다음 구조식 (Ⅴ)의 화합물을 제조하는 단계와, 상기에서 얻어진 다음 구조식(Ⅴ)의 화합물을 알루미나를 이용하여 다음 구조식(Ⅵ)의 화합물과 축합반응시키는 단계로 이루어진 다음 구조식(Ⅰ)의 플루오로 퀴놀린 유도체를 제조하는 방법을 특징으로 한다.The present invention provides a process for preparing a compound of formula (III) by formylating a compound of formula Z (II), and reacting a compound of formula (III) obtained above with a compound of formula (IV) Fluoroquinoline of formula (I), which comprises preparing a compound of formula (V) and condensing the compound of formula (V) obtained above with the compound of formula (VI) using alumina. It is characterized by the method for preparing the derivative.

윗 식에서,In the above formula,

R1은 염소 또는 브롬원자이고,R 1 is chlorine or bromine atom,

R2는 탄소수 5개 이하의 저급알킬기이며,R 2 is a lower alkyl group having 5 or less carbon atoms,

R3은 수소, 메틸기, 에틸기 또는 탄소수가 3개 이하의 저급알칼기이다.R 3 is hydrogen, a methyl group, an ethyl group or a lower alkali group having 3 or less carbon atoms.

이와 같은 본 발명을 더욱 상세히 설명하면 다음과 같다.Referring to the present invention in more detail as follows.

본 발명에 따른 플루오로 퀴놀론 유도체의 제조방법은 먼저, 제 1 단계로서, 상기 구조식(Ⅱ)의 화합물을 포밀화하여 상기 구조식(Ⅲ)의 화합물을 제조한다.In the method for preparing a fluoroquinolone derivative according to the present invention, first, as a first step, the compound of formula (II) is formylated to prepare the compound of formula (III).

즉, 상기 구조식(Ⅲ)의 화합물을 개미산(HCO2H), 소듐포르메이트(HCO2Na)과 아세틸클로리드(CH3COC1)의 혼합물에 0℃의 온도에서 첨가한 후, 약 30분간 반응을 시켜서 상기 구조식(Ⅲ)의 화합물을 제조한다.That is, the compound of formula III is added to a mixture of formic acid (HCO 2 H), sodium formate (HCO 2 Na) and acetyl chloride (CH 3 COC1) at a temperature of 0 ℃, and then reacted for about 30 minutes To prepare a compound of formula (III).

상기 혼합물의 구성비는 상기 구조식(Ⅱ)에 대해서 개미산 : 소듐포르케이트 : 아세틸클로리드가 3 : 1. 1 : 1 당량이며, 이들의 비율을 늘려서 반응을 시킬 수도 있다.The composition ratio of the mixture is 3: 1.1: 1 equivalent of formic acid: sodium formate: acetyl chloride relative to Structural Formula (II), and the reaction may be carried out by increasing the ratio thereof.

상기와 다른 방법으로 상기 구조식(Ⅱ)의 화합물을 개미산(HCO2H)만의 존재하에 약 3시간 동안 환류시켜서 상기 구조식(Ⅲ)의 화합물을 제조할 수 있다.The compound of formula (II) may be prepared by refluxing the compound of formula (II) for about 3 hours in the presence of formic acid (HCO 2 H) alone.

상기 구조식(Ⅱ)의 화합물은 값싸고, 얻기 쉬운 3-클로로-4-플루오로 아닐린 또는 3,4-디플루오로 아닐린을 출발물질로 하여 얻을 수 있으며, 이 방법은 J.Chem. Soc. Chem. Commun, 1987, pp. 897~898에 기재되어 있다.The compound of formula (II) can be obtained using inexpensive, easy to obtain 3-chloro-4-fluoro aniline or 3,4-difluoro aniline as starting material, which is described in J. Chem. Soc. Chem. Commun, 1987, pp. 897-898.

한편, 제 2 단계는 상기 단계에서 얻어진 상기 구조식(Ⅲ)의 화합물을 상기 구조식(Ⅳ)의 화합물과 반응시켜서 상기 구조식(Ⅴ)의 화합물을 제조하는 단계이다.On the other hand, the second step is to prepare a compound of formula (V) by reacting the compound of formula (III) obtained in the step with the compound of the formula (IV).

즉, 상기 구조식(Ⅲ)의 화합물을 포스포러스옥시클로리드(POC13), 포스겐(COC12), 디포스겐, 트리포스겐, 티오닐클로리드(SOC12), 포스포러스옥 시브로미드(POBr3) 또는 포스포러스펜타클로리드(PC15)2~10당량, 바람직하게는 3당량에다 25~150℃, 바람직하게는 80~90℃에서 가한 후에, 상기 구조식(Ⅳ)로 표시되는 알킬말로닐클로리드 또는 모노알킬말로네이트와 반응시키고, 50% 가성소다(HaOH) 수용액으로 액성을 염기성으로 하여 상기 구조식(Ⅴ)의 화합물을 제조한다.That is, the compound of formula III is phosphorus oxcyclolide (POC1 3 ), phosgene (COC1 2 ), diphosgene, triphosgene, thionyl chloride (SOC1 2 ), phosphorus oxybromide (POBr 3 ) Or phosphorus pentachloride (PC1 5 ) 2 to 10 equivalents, preferably 3 equivalents, added at 25 to 150 ° C., preferably 80 to 90 ° C., and then the alkylmalonyl chloride represented by the above formula (IV) The compound of formula (V) is prepared by reacting with lead or monoalkylmalonate and making the liquid basic with a 50% aqueous solution of caustic soda (HaOH).

상기 알킬말로닐클로리드로는 예를들면, 메틸말로닐클로리드, 에틸말로닐클로리드, 이소프로필말로닐클로리드, t -부틸말로닐클로리드가 있다.Examples of the alkylmalonyl chloride include methyl malonyl chloride, ethyl malonyl chloride, isopropyl malonyl chloride, and t-butyl malonyl chloride.

상기 반응의 용매로는 사염화탄소, 벤젠, 톨루엔, 크실렌 또는 아세트니트릴을 사용할 수 있으며, 특히 바람직한 벤젠 또는 톨루엔이다. 필요에 따라서는 상기 용매를 사용하지 않을 수도 있다.Carbon tetrachloride, benzene, toluene, xylene or acetonitrile may be used as the solvent of the reaction, and particularly preferred is benzene or toluene. If necessary, the solvent may not be used.

상기 반응에서, 상기 구조식(Ⅲ)의 화합물 대 상기 구조식(Ⅳ)의 화합물의 반응비는 1 : 0.5~2당량, 바람직하게는 1 : 0.5 당량로 하여 25~150℃, 바람직하게는 80~90℃의 온도에서 약 1시간 동안 반응을 시킨다.In the reaction, the reaction ratio of the compound of formula (III) to the compound of formula (IV) is 1: 150-2 equivalents, preferably 1: 0.5 equivalent, 25-150 ° C., preferably 80-90 The reaction is carried out for about 1 hour at a temperature of ℃.

제 3 단계는 상기에서 얻어진 상기 구조식(Ⅴ)의 화합물을 알루미나를 이용하여 상기 구조식(Ⅵ)의 화합물과 축합반응시켜서 본 발명에서 원하는 상기 구조식(Ⅰ)의 플루오로 퀴놀론 유도체를 제조하는 단계이다.The third step is to prepare a fluoro quinolone derivative of the formula (I) desired in the present invention by condensation reaction of the compound of formula (V) obtained with the compound of formula (VI) using alumina.

즉, 본 발명에 따라 얻은 상기 구조식(Ⅴ)의 화합물과 상기 구조식(Ⅵ)의 피폐라진 유도체등의 아민 유도체와의 축합 반응 방법은 염기의 첨가없이 모핵과 피폐라진의 당량비로의 사용과 알루미나(Al2O3)를 2 내지 10당량, 바람직하기로는 2 내지 4당량을 이용하여 60 내지 120℃ 온도에서 6 내지 24시간동안 반응시켜서 90 내지 98%의 높은 수득률로서 상기 구조식(Ⅰ)로 표시되는 플루오로퀴놀론 유도체를 제조한다.That is, the condensation reaction method of the compound of formula (V) and the amine derivative such as the pyrazine derivative of formula (VI) obtained in accordance with the present invention is used in the equivalence ratio of the mother nucleus and the pyrazine with no addition of base and alumina ( Al 2 O 3 ) is reacted at 2 to 10 equivalents, preferably 2 to 4 equivalents at a temperature of 60 to 120 ° C. for 6 to 24 hours, yielding a high yield of 90 to 98%. Prepare a fluoroquinolone derivative.

이 반응에서 사용하는 용매로는 아세토니트리르 디메틸포름아미드를 사용하는 것이 바람직하고, 특히 아세토니트릴과 디메틸포름아미두가 적합하다.As the solvent used in this reaction, acetonitrile dimethylformamide is preferably used, and acetonitrile and dimethylformamido are particularly suitable.

본 발명에서 사용하는 알루미나로는 산활성(Activated acidic) 알루미나, 중성(Activated neutral) 알루미나 및 염기활성(Activated Basic) 알루미나등이 이용되는데, 이중에서 염기활성 알루미나를 사용하는 것이 바람직하다.As the alumina used in the present invention, an activated acidic alumina, an activated neutral alumina, an activated basic alumina, and the like are used, and among them, a basic active alumina is preferable.

상기 구조식(Ⅴ)의 화합물대 구조식(Ⅵ)의 화합물대 알루미나의 반응비는 1: 1.05 : 1~4의 당량비가 바람직하다. 특히, 염기활성 알루미나를 사용하는 경우에는 알루미나를 1 내지 2 당량으로 반응시키는 것이 조고, 산성, 중성 알루미나를 사용하는 경우에는 알루미나를 3 내지 4당량으로 늘려 사용하는 것이 바람직하다.The reaction ratio of the compound of formula (V) to the compound of formula (VI) to alumina is preferably 1: 1.05: 1 to 4. In particular, in the case of using basic activated alumina, it is preferable to react the alumina in 1 to 2 equivalents, and in the case of using acidic or neutral alumina, it is preferable to increase the alumina to 3 to 4 equivalents.

상기 구조식(Ⅴ)에서 Z가 불소원자인 경우에는 염기활성 알루미나를 사용하여 상기 반응비율을 1 : 1.05~1~2의 당량비로 60℃에서 6시간 반응시키는 것이 바람직하고, Z가 염소원자인 경우에는 120℃에서 24시간 반응시키는 것이 바람직하다. 그리고, 산성, 중성 알루미나를 사용하는 경우에는 알루미나를 3 내지 4당량으로 가열환류하여 10 내지 12시간 동안 반응시키는 것이 바람직하다. 알루미나의 산, 염기 2중성을 가지는 일반적 특성에 관하여는 Solid Acids and Bases(by Kozo Tanabe, Acakemic press, 1970)에 기술되어 있다.In the above formula (V), when Z is a fluorine atom, it is preferable to react the reaction ratio at 60 ° C. for 6 hours using a basic active alumina at an equivalent ratio of 1: 1.05 to 1-2, and Z is a chlorine atom. It is preferable to make it react at 120 degreeC for 24 hours. In addition, when acidic and neutral alumina is used, it is preferable to heat-reflux the alumina to 3 to 4 equivalents and react for 10 to 12 hours. General properties of alumina with acid and base duality are described in Solid Acids and Bases (by Kozo Tanabe, Acakemic press, 1970).

상기 구조식(Ⅰ)의 플루오로 퀴놀론 유도체의 허용가능한 염은 경우에 따라 유기산 또는 무기산과 반응시켜 얻어진 부가염으로써 염산, 브롬산, 황산, 인산, 포름산, 아세트산, 트리플루오로아세트산, 프로피온산, 락트산, 시트르산, 숙신산, 말레인산, 말론산, 푸마르산, 타르타르산, 아스콜빈산, 글룰타민산, 메탄술폰산, 벤젠술폰산, p -톨루엔술폰산 또는 나트륨, 칼륨, 칼슘 또는 마그네슘 등과 3급 또는 4급의 C1-C4알킬암모늄등으로 첨가 제조된다.Acceptable salts of the fluoroquinolone derivatives of the above formula (I) are optionally addition salts obtained by reaction with organic or inorganic acids, such as hydrochloric acid, bromic acid, sulfuric acid, phosphoric acid, formic acid, acetic acid, trifluoroacetic acid, propionic acid, lactic acid, citric acid, succinic acid, maleic acid, malonic acid, fumaric acid, tartaric acid, asbestos Colvin acid, vitamin geulrul acid, methanesulfonic acid, benzenesulfonic acid, p - toluenesulfonic acid, or sodium, potassium, calcium or magnesium as the tertiary or quaternary C 1 -C It is prepared by addition of 4 alkyl ammonium.

다음의 실시예들을 본 발명을 좀 더 자세히 설명하기 위한 것이며, 달리 표시가 없으면 퍼센트, 비율등은 중량에 의한 것이다.The following examples are intended to illustrate the invention in more detail, and unless otherwise indicated, percentages, ratios, etc., are by weight.

실시예 1; 3-클로로-4-플루오로-N-시클로프로필포름아닐리드의 제조.Example 1; Preparation of 3-chloro-4-fluoro-N-cyclopropylformanilide.

개미산 1㎖와 소듐포르메이트 0.83g에 아세틸클로리드 0.78㎖를 0℃에서 적가한 후, 동온도에서 30분 교반한 다음 3-클로로-4-플루오로-N-시클로프로필 아닐린 2g을 개민산 0.3㎖에 용해하여 동온도에서 적가하고 30분 교반하였다. 반응액을 감압농축한 후 에킬아세테이트 20㎖와 물 20㎖를 넣어 층분리하고, 유기층을 5% 중조수 20㎖, 소금물 20㎖순으로 세척하였다. 무수 망초를 가하여 유기층을 건조한 다음 여과하고, 감압농축한 다음, 잔사를 에틸아세테이트와 핵산[1 : 9]의 혼합용액으로 실리카겔 크로마토그래피로 분리정제하여 3-클로로-4-플루오로-N-시클로프로필포름아닐리드 2g(수율 : 88%)을 얻었다.1 ml of formic acid and 0.83 g of sodium formate were added dropwise 0.78 ml of acetyl chloride at 0 ° C., followed by stirring for 30 minutes at the same temperature, followed by 2 g of 3-chloro-4-fluoro-N-cyclopropyl aniline 0.3% It was dissolved in ㎖ dropwise at the same temperature and stirred for 30 minutes. The reaction solution was concentrated under reduced pressure, and 20 ml of ethyl acetate and 20 ml of water were added to separate the layers. The organic layer was washed with 20 ml of 5% sodium bicarbonate and 20 ml of brine. Anhydrous manganese was added, the organic layer was dried, filtered, concentrated under reduced pressure, and the residue was separated and purified by silica gel chromatography with a mixed solution of ethyl acetate and nucleic acid [1: 9] to give 3-chloro-4-fluoro-N-cyclo. 2 g of propylformanilide (yield: 88%) were obtained.

원소분석 : C10H9C1FNOElemental Analysis: C 10 H 9 C1FNO

계산치 : C ; 56.22, H; 4.25, N; 6.56Calculated Value: C; 56.22, H; 4.25, N; 6.56

실측치 : C ; 56.13, H; 4.14, N; 6.49Found: C; 56.13, H; 4.14, N; 6.49

실시예 2; 3-클로로-4-플루오로-N-시클로프로필포름아닐리드의 제조.Example 2; Preparation of 3-chloro-4-fluoro-N-cyclopropylformanilide.

실시예 1에서 소듐 포르메이트와 아세틸크로리드를 사용하지 않고 개미산 10㎖존재하에 3시간 환류시켜 3-클로로-4-플루오로-N-시클로프로 필포름아닐리드 1.74g(수율 : 76%)을 얻었다.In Example 1, the mixture was refluxed for 3 hours in the presence of 10 ml of formic acid without using sodium formate and acetyl chloride, thereby obtaining 1.74 g (yield: 76%) of 3-chloro-4-fluoro-N-cyclopropylformanile. .

실시예 3; 3,4-디플루오로-N-시클로프로필포름아닐리드의 제조.Example 3; Preparation of 3,4-difluoro-N-cyclopropylformanilide.

실시예 1에서 3-클로로-4플루오로-N-시클로프로필아닐린 대신 3,4-디플루오로-N-시클로프로필아닐린 1.82g을 사용하여 3,4-디플루오로-N-시클로프로필포름아닐리드 1.95g(수율 92%)을 얻었다.3,4-difluoro-N-cyclopropylformanilide using 1.82 g of 3,4-difluoro-N-cyclopropylaniline instead of 3-chloro-4fluoro-N-cyclopropylaniline in Example 1 1.95 g (92% yield) was obtained.

원소분석 : C10H9FNOElemental Analysis: C 10 H 9 FNO

계산치 : C ; 60.91, H; 4.60, N; 7.10Calculated Value: C; 60.91, H; 4.60, N; 7.10

실측치 : C ; 60.85, H; 4.54, N; 6.96Found: C; 60.85, H; 4.54, N; 6.96

실시예 4 ; 1-시클로프로필-6-플루오로-7-클로로-1,4-디히드로-4-옥소퀴놀린-3-카르복실산의 제조.Example 4; Preparation of 1-cyclopropyl-6-fluoro-7-chloro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid.

포스포러스옥시클로리드 14㎖에 3-클로로-4-플루오로-N-시클로프로 필포름아닐리드(58.51mmol) 12.5g을 80℃에서 기하고, 10분 후에 메틸말로닐클로리드 8g을 동온도에서 가한 후 1시간 교반하였다. 반응액을 얼음물 24㎖에 넣고 50% 가성소다수로 pH 14로 한 후, 실온에서 하룻밤 교반한 다음 10%염산으로 중화하여 결정화하였다. 생성물을 여과하고 물로 세척한 후, 감압하에 60℃에서 건조하여 조 생성물 16g을 얻었다. 이 고체를 실시카겔 컬럼 크로마토그래피로 분리정제하여 1-시클로프로필-6-플루오로-7-클로로-1,4-디히드로-4-옥소퀴놀린-3-카르복실산 14.3g(수율 87%)을 얻었다.12.5 g of 3-chloro-4-fluoro-N-cyclopropylformanilide (58.51 mmol) was added to 14 ml of phosphorus oxcyclolide at 80 ° C, and after 10 minutes, 8 g of methylmalonyl chloride was stirred at the same temperature. After the addition, the mixture was stirred for 1 hour. The reaction solution was poured into 24 ml of iced water, adjusted to pH 14 with 50% caustic soda water, stirred overnight at room temperature, and neutralized with 10% hydrochloric acid to crystallize. The product was filtered off, washed with water and dried at 60 ° C. under reduced pressure to yield 16 g of crude product. This solid was separated and purified through elution gel gel column chromatography, 14.3 g of 1-cyclopropyl-6-fluoro-7-chloro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid (yield 87%) Got.

원소분석 : C10H9C1FNO3 Elemental Analysis: C 10 H 9 C1FNO 3

계산치 : C ; 55.43, H; 3.22, N; 4.97Calculated Value: C; 55.43, H; 3.22, N; 4.97

실측치 : C ; 55.36, H; 3.15, N; 4.88Found: C; 55.36, H; 3.15, N; 4.88

실시예 5; 1-시클로프로필-6-플루오로-7-클로로-1,4-디히드로-4-옥소퀴놀린-3-카르복실산의 제조.Example 5; Preparation of 1-cyclopropyl-6-fluoro-7-chloro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid.

실시예 4에서 메틸말로닐클로리드 대신 모노 에틸말로네이트 7.7g을 사용하여 1-시클로프로필-6-플루오로-7-클로로-1,4-디히드로-4-옥소쿠놀린-3-카르복실산 13.5g(수율 : 82%)을 얻었다.1-cyclopropyl-6-fluoro-7-chloro-1,4-dihydro-4-oxokunolin-3-carboxyl using 7.7 g of mono ethylmalonate instead of methylmalonyl chloride in Example 4 An acid 13.5 g (yield: 82%) was obtained.

실시예 6; 1-시클로프로필-6-플루오로-7-클로로-1,4-디히드로-4-옥소퀴놀린-3-카르복실산의 제조.Example 6; Preparation of 1-cyclopropyl-6-fluoro-7-chloro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid.

건조된 벤젠 60㎖에 포스포러스펜타크로리드 36.6g, 3-클로로-4-플루오로-N-시클로프로필포름아닐리드 12.5g을 가한후 2시간 환류시킨 후, 메틸말로닐클로리드 4g을 동 온도에서 적가하여 1시간 교반하였다. 이후의 과정은 실시예 4과 동일하게 하여 1-시클로프로필-6-플루오로-7-클로로1,4-디히드로-4-옥소퀴놀린-3-카르복실산 14g(수율 : 85%)을 얻었다.After adding 36.6 g of phosphorus pentachloride and 12.5 g of 3-chloro-4-fluoro-N-cyclopropylformanilide to 60 ml of dried benzene, the mixture was refluxed for 2 hours, and then 4 g of methylmalonyl chloride was added at the same temperature. It was added dropwise and stirred for 1 hour. The procedure was followed in the same manner as in Example 4 to obtain 14 g of 1-cyclopropyl-6-fluoro-7-chloro1,4-dihydro-4-oxoquinoline-3-carboxylic acid (yield: 85%). .

실시예 7; 1-시클로프로필-6,7-디플루오로-1,4-디히드로-4-옥소퀴놀린-3-카프복실산의 제조.Example 7; Preparation of 1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-cafic acid.

포스포러스옥시클로리드 14㎖에 3,4-디플루오로-N-시클로프로필 포름아니리드 11g을 80℃에서 가하고 10분 후에 에틸말로닐클로리드 8.4g을 동온도에서 가한 다음 1시간 교반하였다. 반응액을 얼음물 30㎖에 넣고 50% 가성소다수로 pH 14로 한 후, 실온에서 하룻밤 교반한 다음 10%염산으로 중화하여 결정화 하였다. 생성물을 여과하고 물로 세척한 감압하에 60℃에서 건조하고,이 고체를 실시카겔 컬럼크로마토 그래피로 분리정제하여 1-시클로프로필-6,7-디플루오로-1,4-디히드로-4-옥소퀴놀린-3-카르복실산 -12.2g(수율 83%)을 얻었다.11 g of 3,4-difluoro-N-cyclopropyl formanilide was added to 14 ml of phosphorus oxcyclolide at 80 ° C., and after 10 minutes, 8.4 g of ethylmalonyl chloride was added at the same temperature, followed by stirring for 1 hour. The reaction solution was poured into 30 ml of iced water to pH 14 with 50% caustic soda water, stirred overnight at room temperature and neutralized with 10% hydrochloric acid to crystallize. The product was filtered, dried with water under reduced pressure, washed with water, and dried at 60 ° C., and the solid was separated and purified through preparative Kagel column chromatography to give 1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxo. Quinoline-3-carboxylic acid -12.2 g (yield 83%) was obtained.

원소분석 : C14H10F2O3 Elemental Analysis: C 14 H 10 F 2 O 3

계산치 : C ; 58.487, H; 3.42, N; 5.28Calculated Value: C; 58.487, H; 3.42, N; 5.28

실측치 : C ; 58.82, H; 3.35, N; 5.21Found: C; 58.82, H; 3.35, N; 5.21

실시예 8 ; 1-시클로프로필-6,7-디플루오로-1,4-디히드로-4-옥소퀴놀린-3-카르복실산의 제조.Example 8; Preparation of 1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid.

실시예 7에서 에킬말로닐클로리드 대신에 이소프로필말로닐클로리드 9.1g을 사용하여 1-시클로프로필-6,7-디플루오로-1,4-디히드로-4-옥소퀴놀린-3-카르복실산 12.8g(수율 : 87%)을 얻었다.1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carrine using 9.1 g of isopropylmalonyl chloride instead of ekymalonyl chloride in Example 7 An acid 12.8 g (yield: 87%) was obtained.

실시예 9 ; 1-시클로프로필-6,7-디플루오로-1,4-디히드로-4-옥소퀴놀린-3-카르복실산의 제조.Example 9; Preparation of 1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid.

실시예 7에서 에킬말로닐클로리드 대신에 t-부틸말로닐클로리드 10g을 사용하여 1-시클로프로필-6,7-디플루오로-1,4-디히드로-4-옥소퀴놀린-3-카르복실산 11.8g(수율 : 80%)을 얻었다.Example 7 1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carrine using 10 g of t-butylmalonyl chloride instead of ekymalonyl chloride An acid 11.8 g (yield: 80%) was obtained.

실시예 10 ; 1-시클로프로필-6,7-디플루오로-1,4-디히드로-4-옥소퀴놀린-3-카르복실산의 제조.Example 10; Preparation of 1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid.

3,4-디플루오로-N-시클로프로필포름아닐리드 1.1g, 메틸말로닐클로리드 1.2㎖를 톨루엔 12㎖에 용해시킨후 40℃에서 하룻밤 교반하였다. 감압농축하여 용매를 제거한 후, 여기서 물 14㎖를 넣고 1시간 교반한 후 빙초산 17㎖, 진한황산 1.78㎖를 넣고 1시간 가열 환류한 후 생성된 고체를 여과 건조하여 1-시클로프로필-6,7-디플루오로-1,4-디히드로-4-옥소퀴놀린-카르복실산 1.25g(수율 : 85%)을 얻었다.1.1 g of 3,4-difluoro-N-cyclopropylformanilide and 1.2 ml of methylmalonyl chloride were dissolved in 12 ml of toluene, followed by stirring at 40 ° C overnight. After concentration under reduced pressure, the solvent was removed, and 14 ml of water was added thereto, followed by stirring for 1 hour. Then, 17 ml of glacial acetic acid and 1.78 ml of concentrated sulfuric acid were added and refluxed for 1 hour. The resulting solid was filtered and dried to form 1-cyclopropyl-6,7. 1.25 g (yield: 85%) of -difluoro-1,4-dihydro-4-oxoquinoline-carboxylic acid were obtained.

실시예 11 ; 1-시클로프로필-7-클로로-6-플루오로-1,4-디히드로-4-옥소퀴놀린-3-카르복실산의 제조.Example 11; Preparation of 1-cyclopropyl-7-chloro-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid.

벤젠 8㎖에 티오닐클로리드 2㎖, 3-클로로-4-플루오로-N-시클로프로필포름아닐리드 1g, 에틸말로닐클로리드 0.71㎖을 가하여 75℃에서 하룻밤 교반하였다. 감압농축하여 용매를 제거한 후 빙초산 13.8㎖, 물 12㎖, 진한 황산 1.44㎖를 넣고 1시간 가열 환류한 후 생성된 고체를 여과 건조하여 1-시클로프로필-7-클로로-6-플루오로-1,4-디히드로-4-옥소퀴놀린-3-카르복실산 1g(수율 : 81%)을 얻었다.To 8 ml of benzene, 2 ml of thionyl chloride, 1 g of 3-chloro-4-fluoro-N-cyclopropylformanilide, and 0.71 ml of ethylmalonyl chloride were added, and the mixture was stirred overnight at 75 ° C. After concentration under reduced pressure, the solvent was removed, 13.8 ml of glacial acetic acid, 12 ml of water and 1.44 ml of concentrated sulfuric acid were added thereto, and the mixture was heated to reflux for 1 hour, and then the resulting solid was filtered and dried to obtain 1-cyclopropyl-7-chloro-6-fluoro-1, 1 g (yield: 81%) of 4-dihydro-4-oxoquinoline-3-carboxylic acid was obtained.

실시예 12 ; 1-시클로프로필-6-플루오로-7-피페라지닐-1,4-디히드로-4-옥소퀴놀린-3-카르복실산의 제조.Example 12; Preparation of 1-cyclopropyl-6-fluoro-7-piperazinyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid.

실시예 4에서 얻은 1-시클로프로필-6-플루오로-7-클로로-1,4-디히드로-4-옥소퀴놀린-3-카르복실산 0.14g과 피페라진 0.05g, 염기성알루미나 0.05g을 무수 아세토니트릴 5㎖에 섞고 가열환류하며 24시간 교반하고, 혼합물을 냉각 후 생성된 고체 생성물을 여과하였다. 고체 생성물은 클로로포름 : 메탄올=3 : 1의 용매에 가하여 녹지 않는 고체는 셀라이트(celite)하에서 여과하여 제거하여 제거하고 20분간 교반하고, 여액을 감압건조하여 상기 표제화합물 0.16g(95%)을 얻었다.0.14 g of 1-cyclopropyl-6-fluoro-7-chloro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, 0.05 g of piperazine and 0.05 g of basic alumina obtained in Example 4 were dried. 5 ml of acetonitrile were mixed, heated to reflux and stirred for 24 hours, and the resulting solid product was filtered after cooling the mixture. The solid product was added to a solvent of chloroform: methanol = 3: 1, and the insoluble solid was removed by filtration under celite. The solid product was stirred for 20 minutes, and the filtrate was dried under reduced pressure to give 0.16 g (95%) of the title compound. Got it.

원소분석 : C17H18FN3O3 Elemental Analysis: C 17 H 18 FN 3 O 3

계산치 : C ; 61.62, H; 5.47, N; 12.68Calculated Value: C; 61.62, H; 5.47, N; 12.68

실측치 : C ; 61.60, H; 5.42, N; 12.70Found: C; 61.60, H; 5.42, N; 12.70

실시예 13 ; 1-시클로프로필-6-플루오로-7-피페라지닐-1,4-디히드로-4-옥소퀴놀린-3-카르복실산의 제조.Example 13; Preparation of 1-cyclopropyl-6-fluoro-7-piperazinyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid.

실시예 12에서 반응 용매를 아세토니트릴 대신에 디메틸포름아미드 5㎖를 사용하고 120℃에서 12시간 반응하여 1-시클로프로필-6-플루오로-7-피페라지닐-1,4-디히드로-4-옥소퀴놀린-3-카르복실산 0.162g(수율 : 98%)을 얻었다.In Example 12, 1 mL of 1-cyclopropyl-6-fluoro-7-piperazinyl-1,4-dihydro-4 was reacted with 5 ml of dimethylformamide in place of acetonitrile and reacted at 120 DEG C for 12 hours. 0.162 g of oxoquinoline-3-carboxylic acid (yield: 98%) was obtained.

실시예 14 ; 1-시클로프로필-6-플루오로-7-피페라지닐-1,4-디히드로-4-옥소퀴놀린-3-카르복실산의 제조.Example 14; Preparation of 1-cyclopropyl-6-fluoro-7-piperazinyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid.

실시예 12에서 염기성 알루미나 대신 산성알루미나 0.2g(4당량)을 사용하고 아세트니트릴 5㎖용매에서 가열환류하여 120℃에서 24시간 동안 반응하여 1-시클로프로필-6-플루오로-7-피페라지닐-1,4-디히드로-4-옥소퀴놀린-3-카르복실산 0.15g(91%)을 얻었다.In Example 12, 1-cyclopropyl-6-fluoro-7-piperazinyl was used by using 0.2 g (4 equivalents) of acidic alumina instead of basic alumina and reacting by heating under reflux in acetonitrile 5 ml for 24 hours at 120 ° C. 0.15 g (91%) of -1,4-dihydro-4-oxoquinoline-3-carboxylic acid was obtained.

실시예 15 ; 1-시클로프로필-6-플루오로-7-피페라지닐-1,4-디히드로-4-옥소퀴놀린-3-카르복실산의 제조.Example 15; Preparation of 1-cyclopropyl-6-fluoro-7-piperazinyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid.

실시예 12에서 염기성 알루미나 대신 중성알루미나 0.15g(3당량)을 사용하여 상기 실시예 14와 동일한 방법에 의하여 1-시클로프로필-6-플루오로-7-피페라지닐-1,4-디히드로-4-옥소퀴놀린-3-카르복실산 0.154g(수율 : 93%)을 얻었다.In Example 12, 1-cyclopropyl-6-fluoro-7-piperazinyl-1,4-dihydro- was prepared in the same manner as in Example 14, using 0.15 g (3 equivalents) of neutral alumina instead of basic alumina. 0.154 g (yield: 93%) of 4-oxoquinoline-3-carboxylic acid was obtained.

실시예 16 ; 1-시클로프로필-6-플루오로-7-피페라지닐-1,4-디히드로-4-옥소퀴놀린-3-카르복실산의 제조.Example 16; Preparation of 1-cyclopropyl-6-fluoro-7-piperazinyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid.

실시예 14에서, 반응 용매를 디메틸포름아미드 5㎖를 사용하고 상기 실시예 13과 동일한 조건에 의한 방법으로 반응하여 1-시클로프로필-6-플루오로-7-피페라지닐-1,4-디히드로-4-옥소퀴놀린-3-카르복실산 0.157g(수율 : 95%)을 얻었다.In Example 14, 1-cyclopropyl-6-fluoro-7-piperazinyl-1,4-di was reacted using 5 ml of dimethylformamide in the same manner as in Example 13 above. 0.157 g (yield: 95%) of hydro-4-oxoquinoline-3-carboxylic acid was obtained.

실시예 17 ; 1-시클로프로필-6-플루오로-7-피페라지닐-1,4-디히드로-4-옥소퀴놀린-3-카르복실산의 제조.Example 17; Preparation of 1-cyclopropyl-6-fluoro-7-piperazinyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid.

실시예 15에서 반응용매를 아세토니트릴 대신에 디메틸 포름아미드 5㎖를 사용하고 상기 실시예 13과 동일한 조건에 의한 방법으로 1-시클로프로필-6-플루오로-7-피페라지닐-1,4-디히드로-4-옥소퀴놀린-3-카르복실산 0.148g(수율 : 90%)을 얻었다.Example 1 1-cyclopropyl-6-fluoro-7-piperazinyl-1,4- using 5 ml of dimethyl formamide instead of acetonitrile as a reaction solvent in the same manner as in Example 13 above. 0.148 g (yield: 90%) of dihydro-4-oxoquinoline-3-carboxylic acid was obtained.

실시예 18 ; 1-시클로프로필-6-플루오로-7-피페라지닐-1,4-디히드로-4-옥소퀴놀린-3-카르복실산의 제조.Example 18; Preparation of 1-cyclopropyl-6-fluoro-7-piperazinyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid.

실시예 7에서 얻은 1-시클로프로필-6,7-디플루오로-1,4-디히드로-4-옥소퀴놀린-3-카르복실산 0.265g과 피페라진 0.088g, 염기성알루미나 0.102g을 무수 아세트니트릴 5㎖에 섞고 60℃에서 6시간 교반하였다. 냉각 후 감압증류하여 용매를 제거한 후 물 10㎖를 가하고, 10%염산수용액으로 산성화(pH 2∼3)하였다. 셀라이트하에서 녹지 않는 고체를 여과하여 제거하고, 여액을 10%가성소다수로 중화하여 생성된 고체를 여과하였다. 얻어진 고체 생성물을 감압 건조하여 1-시클로프로필-6-플루오로-7-피페라지닐-1,4-디히드로-4-옥소퀴놀린-3-카르복실산 0.324g(98%)을 얻었다.0.265 g of 1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, 0.088 g of piperazine and 0.102 g of basic alumina obtained in Example 7 were acetic anhydride. It was mixed with 5 ml of nitrile and stirred at 60 ° C for 6 hours. After cooling, the mixture was distilled under reduced pressure to remove the solvent, and 10 ml of water was added thereto, followed by acidification (pH 2 to 3) with 10% aqueous hydrochloric acid solution. The insoluble solids were removed by filtration under celite and the filtrate was neutralized with 10% caustic soda water to filter the resulting solids. The obtained solid product was dried under reduced pressure to obtain 0.324 g (98%) of 1-cyclopropyl-6-fluoro-7-piperazinyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid.

원소분석 : C17H18FN3O3 Elemental Analysis: C 17 H 18 FN 3 O 3

계산치 : C ; 61.62, H; 5.47, N; 12.68Calculated Value: C; 61.62, H; 5.47, N; 12.68

실측치 : C ; 61.28, H; 5.50, N; 12.74Found: C; 61.28, H; 5.50, N; 12.74

실시예 19 ; 1-시클로프로필-6-플루오로-7-피페라지닐-1,4-디히드로-4-옥소퀴놀린-3-카르복실산의 제조.Example 19; Preparation of 1-cyclopropyl-6-fluoro-7-piperazinyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid.

실시예 18에서 반응 용매로 아세토니트릴 대신에 디메틸포름아미드 5㎖를 사용하여 60℃에서 3시간 반응 후 생성된 고체를 여과하고, 물로 씻어준 후 클로로포름 : 메탄올-3 : 1 용매에서 20∼30분간 교반하였다. 이 후의 과정은 실시예 13과 동일하게 하여 1-시클로프로필-6-플루오로-7-피페라지닐-1,4-디히드로-4-옥소퀴놀린-3-카르복실산 0.321g(97%)을 얻었다.In Example 18, 5 ml of dimethylformamide instead of acetonitrile was used as a reaction solvent, and the solid formed after the reaction at 60 ° C. for 3 hours was filtered, washed with water, and then chloroform: methanol-3: 1 in 20 to 30 minutes. Stirred. The subsequent procedure was the same as in Example 13, 0.321 g (97%) of 1-cyclopropyl-6-fluoro-7-piperazinyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid Got.

실시예 20 ; 1-시클로프로필-6-플루오로-7-피페라지닐-1,4-디히드로-4-옥소퀴놀린-3-카르복실산의 제조.Example 20; Preparation of 1-cyclopropyl-6-fluoro-7-piperazinyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid.

실시예 18에서 염기성 알루미나 대신에 산성알루미나 0.404g을 사용하여 동일한 조건에서 반응 후 실시예 19의 과정과 동일하게 실시하여 1-시클로프로필-6-플루오로-7-피페라지닐-1,4-디히드로-4-옥소퀴놀린-3-카르복실산 0.314g(수율 : 95%)을 얻었다.In Example 18, 1-cyclopropyl-6-fluoro-7-piperazinyl-1,4- was carried out in the same manner as in Example 19 after reaction under the same conditions using 0.404 g of acidic alumina instead of basic alumina. 0.314 g (yield: 95%) of dihydro-4-oxoquinoline-3-carboxylic acid was obtained.

실시예 21 ; 1-시클로프로필-6-플루오로-7-피페라지닐-1,4-디히드로-4-옥소퀴놀린-3-카르복실산의 제조.Example 21; Preparation of 1-cyclopropyl-6-fluoro-7-piperazinyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid.

실시예 18에서 염기성 알루미나 대신에 중성알루미나 0.303g을 사용하여 동일한 조건에서 반응 후 실시예 19의 과정과 동일하게 실시하여 1-시클로프로필-6-플루오로-7-피페라지닐-1,4-디히드로-4-옥소퀴놀린-3-카르복실산 0.308g( 93%)을 얻었다.In Example 18, using 0.303 g of neutral alumina instead of basic alumina, the reaction was carried out in the same manner as in Example 19, followed by 1-cyclopropyl-6-fluoro-7-piperazinyl-1,4- 0.308 g (93%) of dihydro-4-oxoquinoline-3-carboxylic acid was obtained.

실시예 22 ; 1-시클로프로필-6-플루오로-7-피페라지닐-1,4-디히드로-4-옥소퀴놀린-3-카르복실산 염산염의 제조.Example 22; Preparation of 1-cyclopropyl-6-fluoro-7-piperazinyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid hydrochloride.

1-시클로프로필-6-플루오로-7-피페라지닐-1,4-디히드로-4-옥소퀴놀린-3-카르복실산 0.33g을 클로로포름 : 메탄올 = 3 : 1용매에 녹인후 메탄올에 5중량%로 포화된 염산 용액 20㎖를 가하고 상온에서 3시간 교반하였다. 반응 용매를 감압증류하여 제거하고 얻어진 고체 잉여물에 냉각하에서 디에틸에테르를 가하여 생성된 고체를 여과한 후 감압 건조하여 1-시클로프로필-6-플루오로-7-피페라지닐-1,4-디히드로-4-옥소퀴놀린-3-카르복실산 염산염 0.35g( 95%)을 얻었다.0.33 g of 1-cyclopropyl-6-fluoro-7-piperazinyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid was dissolved in chloroform: methanol = 3: 1 solvent, and then dissolved in methanol. 20 ml of saturated hydrochloric acid solution was added and stirred at room temperature for 3 hours. The reaction solvent was distilled off under reduced pressure, and diethyl ether was added to the obtained solid surplus under cooling, and the resulting solid was filtered and dried under reduced pressure to yield 1-cyclopropyl-6-fluoro-7-piperazinyl-1,4-di. 0.35 g (95%) of hydro-4-oxoquinoline-3-carboxylic acid hydrochloride was obtained.

원소분석 : C17H19C1FN3O3 Elemental analysis: C 17 H 19 C1FN 3 O 3

계산치 : C ; 58.54%, H; 5.49%, N; 12.05%Calculated Value: C; 58.54%, H; 5.49%, N; 12.05%

실측치 : C ; 58.60%, H; 5.95%, N; 12.12%Found: C; 58.60%, H; 5.95%, N; 12.12%

실시예 23 ; 1-시클로프로필-6-플루오로-7-피페라지닐-1,4-디히드로-4-옥소퀴놀린-3-카르복실산 락트산염의 제조.Example 23; Preparation of 1-cyclopropyl-6-fluoro-7-piperazinyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid lactate.

1-시클로프로필-6-플루오로-7-피페라지닐-1,4-디히드로-4-옥소퀴놀린-3-카르복실산 0.33g을 클로로포름 : 메탄올 = 3 : 1용매에 녹인 후 락트산 0.11g을 가하여 2∼3시간 교반하였다. 반응 용매를 감압증류하여 제거하고 얻어진 고체잉여물에 냉각하에서 디에틸에테르를 가하여 생성된 고체를 여과한 후 감압건조하여 1-시크로프로필-6-플루오로-7-피페라지닐-1,4-디히드로-4-옥소퀴놀린-3-카르복실산 락트산염 0.38g( 93%)을 얻었다.0.33 g of 1-cyclopropyl-6-fluoro-7-piperazinyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid was dissolved in chloroform: methanol = 3: 1 solvent and lactic acid 0.11 g Was added and stirred for 2-3 hours. The reaction solvent was distilled off under reduced pressure, and diethyl ether was added to the obtained solid surplus under cooling, and the resulting solid was filtered and dried under reduced pressure to yield 1-cyclopropyl-6-fluoro-7-piperazinyl-1,4- 0.38 g (93%) of dihydro-4-oxoquinoline-3-carboxylic acid lactate was obtained.

원소분석 : C21H24FN3O7 Elemental analysis: C 21 H 24 FN 3 O 7

계산치 : C ; 56.12%, H; 5.38%, N; 9.35%Calculated Value: C; 56.12%, H; 5.38%, N; 9.35%

실측치 : C ; 56.38%, H; 5.99%, N; 9.38%Found: C; 56.38%, H; 5.99%, N; 9.38%

본 발명에 의한 구조식(Ⅴ)에 대한 제조방법과 종래의 기술에 의한 차이점을 반응식으로 요약하면 다음과 같다.Differences between the manufacturing method for the structural formula (V) according to the present invention and the prior art are summarized as follows.

[공지의 방법][Method of notification]

[본 발명에 의한 방법][Method according to the present invention]

윗 식에서, R1, R2는 상기한 바와 같고, X는 염소 나 불소등의 할로겐 원자이다.In the above formula, R 1 , R 2 are as described above, and X is a halogen atom such as chlorine or fluorine.

그리고, 이미 공지된 종래의 축합 반응 방법은 일반적으로 염기로서 DBU, 트리에틸아민, 탄산칼륨 등을 사용하거나 또는 디메틸설폭시드 또는 피리딘 용매하에서 과량의 피레라진을 사용하고, 고온에서 반응시키는 방법들인데, DBU사용의 경우 DBU자체의 산화에 의한 물질의 변화에 따른 부생성물이 생기며 또한, 가격이 비싸다는 단점을 내포하고 있다.In addition, conventionally known condensation reaction methods are generally those which use DBU, triethylamine, potassium carbonate, etc. as a base, or an excess of pyrerazine in a dimethyl sulfoxide or pyridine solvent, and react at a high temperature. In the case of using DBU, by-products are produced due to the change of substances by oxidation of DBU itself, and the price is expensive.

그러나, 본 발명에 의한 상기의 축합반응 비용이 적게들며, 루이스산(Lewis acid)성질과 브뢴스테드 염기(Broensted base)의 성질을 가지는 알루미나를 사용하여 비교적 낮은 온도에서 다른 부 생성물의 생성이 전혀 없이 높은 수득률과 간편한 공정으로 상기 구조식(Ⅰ)의 플루오로퀴놀론 유도체를 얻는 장점을 가지고 있다.However, the cost of the condensation reaction according to the present invention is low, and the production of other side products at relatively low temperatures is completely avoided by using alumina having Lewis acid properties and Broensted base properties. It has the advantage of obtaining the fluoroquinolone derivative of formula (I) in a high yield and a simple process without.

또한, 본 발명의 방법에 의하여 얻어진 구조식(Ⅰ)의 화합물과 기존의 방법에 의하여 얻어진 구조식(Ⅰ)의 화합물에 대해 실험적 결과를 반응식으로 나타내면 다음과 같다.In addition, the experimental results of the compound of Structural Formula (I) obtained by the method of the present invention and the compound of Structural Formula (I) obtained by the existing method are shown in the following scheme.

(기존의 방법)(Existing method)

(본 발명에 의한 방법)(Method according to the present invention)

상기 식에서 Z, R3는 상기와 동일하다.In the above formula, Z, R 3 are the same as above.

상기 구조식(Ⅰ)의 화합물의 제조방법에서, 공지의 방법과 본 발명에 의한 방법의 차이점과 그에 대한 효과를 비교하면 다음 표 1과 같다.In the preparation method of the compound of formula (I), the difference between the known method and the method according to the present invention and the effects thereof are as follows in Table 1.

[표 1]TABLE 1

상기 구조식(Ⅰ)의 화합물의 제조방법에서, 공지의 방법과 본 발명에 의한 방법의 차이점과 그에 대한 효과를 비교하면 다음 표 2와 같다.In the method for preparing the compound of formula (I), the difference between the known method and the method according to the present invention and the effects thereof are as follows in Table 2.

[표 2]TABLE 2

1) American Cyanamid 등1) American Cyanamid, etc.

2) C-7 : 염소인 경우 ; 본 발명에 의한 방법의 경우 아세토니트릴과 알루미나(basic) 사용, 12시간 동안 가열환류함.2) C-7: chlorine; For the process according to the invention using acetonitrile and alumina (basic), heated to reflux for 12 hours.

3) Bayer AG. 등3) Bayer AG. Etc

Claims (16)

(1) 다음 구조식(Ⅱ)의 화합물을 포밀화하여 다음 구조식(Ⅲ)의 화합물을 제조하는 단계와, (2) 상기에서 얻어진 다음 구조식(Ⅲ)의 화합물을 다음 구조식(Ⅳ)의 화합물과 반응시켜서 다음 구조식(Ⅴ)의 화합물을 제조하는 단계와, (3) 상기에서 얻어진 다음 구조식(Ⅴ)의 화합물을 알루미나를 이용하여 다음 구조식(Ⅳ)과 축합반응시키는 단계로 이루어진 다음 구조식(Ⅰ)의 플루오로 퀴놀린 유도체의 제조방법.(1) forming a compound of formula (III) by formylating a compound of formula (II), and (2) reacting a compound of formula (III) obtained above with a compound of formula (IV) Preparing a compound of the following structural formula (V), and (3) condensing the compound of the following structural formula (V) obtained above with the following structural formula (IV) using alumina. Method for preparing fluoro quinoline derivatives. 윗 식에서, R1은 염소 또는 브롬원자이고, R2는 탄소수 5개 이하의 저급알킬기이며, R3은 수소, 메틸기, 에킬기 또는 탄소수가 3개 이하의 저급알킬기이다.Wherein R 1 is a chlorine or bromine atom, R 2 is a lower alkyl group of up to 5 carbon atoms, and R 3 is hydrogen, a methyl group, an alkyl group or a lower alkyl group of 3 or less carbon atoms. 제 1 항에 있어서, 상기 단계(1)은 상기 구조식(Ⅱ)의 화합물을 3 : 1.1 : 1의 당량비를 갖는 개미산, 소듐포르메이트 및 아세틸클로리드 혼합물에 첨가하여 반응시켜서 됨을 특징으로 하는 방법.The method of claim 1, wherein step (1) is performed by adding the compound of formula II to a formic acid, sodium formate and acetyl chloride mixture having an equivalent ratio of 3: 1.1: 1. 제 2 항에 있어서, 상기 단계(1)의 반응은 0℃의 온도에서 실시함을 특징으로 하는 방법.The method of claim 2, wherein the reaction of step (1) is carried out at a temperature of 0 ° C. 제 1 항에 있어서, 상기 단계(1)은 상기 구조식(Ⅱ)의 화합물을 개미산에만 첨가하고 환류시켜서 됨을 특징으로 하는 방법.The method according to claim 1, wherein step (1) is performed by adding the compound of formula II only to formic acid and refluxing. 제 1 항에 있어서, 상기 단계(2)는 상기 구조식(Ⅲ)의 화합물을 포스포러스옥시클로리드, 포스겐, 디포스겐, 트리포스겐, 티오닐클로리드, 포스포러스옥시브로미드 또는 포스포러스펜타클로리드의 존재하에 상기구조식(Ⅳ)와 반응시킴을 특징으로 하는 방법.The method of claim 1, wherein the step (2) comprises the step of replacing the compound of formula III by phosphorus oxcyclolide, phosgene, diphosgene, triphosphogen, thionyl chloride, phosphorus oxybromide or phosphorus pentachloride. Reacting with the above formula (IV) in the presence of 제 1 항 또는 제 5 항에 있어서, 상기 구조식(Ⅲ)의 화합물 대 상기 구조식(Ⅳ)의 화합물의 반응비는 1 : 0.5∼2당량, 바람직하게 1 : 0.5 당량으로 하여서 됨을 특징으로 하는 방법.A process according to claim 1 or 5, characterized in that the reaction ratio of the compound of formula (III) to the compound of formula (IV) is 1: 0.5 to 2 equivalents, preferably 1: 0.5 equivalent. 제 1 항 또는 제 5 항에 있어서, 상기 구조식(Ⅲ)의 화합물과 상기 구조식(Ⅳ)의 화합물은 25∼150℃, 바람직하게 80∼90℃의 온도하에서 실시함을 특징으로 하는 방법.The method according to claim 1 or 5, wherein the compound of formula (III) and the compound of formula (IV) are carried out at a temperature of 25 to 150 ° C, preferably 80 to 90 ° C. 제 1 항 또는 제 5 항에 있어서, 상기 단계(2)의 반응은 용매로서 사염화탄소, 벤젠, 톨루엔, 크실렌 또는 아세트니트릴, 바람직한 것은 벤젠 또는 톨루엔을 사용하거나 용매를 사용하지 않는 것임을 특징으로 하는 방법.6. Process according to claim 1 or 5, characterized in that the reaction of step (2) uses carbon tetrachloride, benzene, toluene, xylene or acetonitrile as solvent, preferably benzene or toluene or no solvent. 제 1 항에 있어서, 상기 단계(3)의 알루미나는 산성알루미나, 중성알루미나 또는 염기성알루미나, 바람직하게는 염기성알루미나를 사용하여서 됨을 특징으로 하는 방법.A process according to claim 1, characterized in that the alumina of step (3) is made using acidic alumina, neutral alumina or basic alumina, preferably basic alumina. 제 1 항에 있어서, 상기 단계(3)의 축합반응은 약 60∼120℃의 온도에서 실시함을 특징으로 하는 방법.The method of claim 1, wherein the condensation reaction of step (3) is carried out at a temperature of about 60 to 120 ℃. 제 1 항에 있어서, 상기 단계(3)의 축합반응시의 용매로는 아세트니트릴, 피리딘, 디메틸포름아미드, 디메틸설폭시드, 헥사메틸렌포스포아미드 또는 헥사메틸렌 포스트리아미드, 바람직하게는 아세토니트릴 또는 디메틸포름아미드를 사용하여서 됨을 특징으로 하는 방법,A solvent according to claim 1, wherein the solvent in the condensation reaction of step (3) is acetonitrile, pyridine, dimethylformamide, dimethylsulfoxide, hexamethylenephosphoramide or hexamethylene postriamide, preferably acetonitrile or Characterized in that by using dimethylformamide, 제 1 항에 있어서, 상기 구조식(Ⅴ) : 상기 구조식(Ⅵ) : 알루미나의 반응비는 1 : 1.05 : 1∼4 당량으로 함을 특징으로 하는 방법.The method of claim 1, wherein the reaction ratio of Structural Formula (V): Structural Formula (VI): Alumina is 1: 1.05: 1 to 4 equivalents. 제 12 항에 있어서, 상기 알루미나가 산성알루미나 또는 중성알룸L나인 경우에는 3∼4당량을 사용하여서 됨을 특징으로 하는 방법.The method according to claim 12, wherein when the alumina is acidic alumina or neutral alum L, 3 to 4 equivalents are used. 제 1 항, 제12항 또는 제13항에 있어서, 반응조건은 가열환류하여 10∼12시간 동안 반응시킴을 특징으로 하는 방법.The method of claim 1, 12 or 13, wherein the reaction conditions are heated to reflux for 10 to 12 hours. 제12항에 있어서, 상기 알루미나가 염기성 알루미나인 경우에는 1∼2당량을 사용하여서 도미을 특징으로 하는 방법.13. The method according to claim 12, wherein when the alumina is basic alumina, sea bream is used using 1 to 2 equivalents. 제 1 항, 제12항 또는 제15항에 있어서, 반응조건은 C-7원자가 불소인 경우에는 60℃에서 6시간동안 반응시키고, C-7원자가 염소인 경우에는 가열환류하여 24시간 동안 반응시킴을 특징으로 하는 방법.According to claim 1, 12 or 15, the reaction conditions are reacted for 6 hours at 60 ℃ when the C-7 atom is fluorine, heated for 24 hours when the C-7 atom is chlorine Characterized by the above.
KR1019930000891A 1993-01-26 1993-01-26 Process for preparing fluoro quinoline derivatives KR0130886B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019930000891A KR0130886B1 (en) 1993-01-26 1993-01-26 Process for preparing fluoro quinoline derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019930000891A KR0130886B1 (en) 1993-01-26 1993-01-26 Process for preparing fluoro quinoline derivatives

Publications (2)

Publication Number Publication Date
KR940018378A KR940018378A (en) 1994-08-16
KR0130886B1 true KR0130886B1 (en) 1998-04-23

Family

ID=19349947

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930000891A KR0130886B1 (en) 1993-01-26 1993-01-26 Process for preparing fluoro quinoline derivatives

Country Status (1)

Country Link
KR (1) KR0130886B1 (en)

Also Published As

Publication number Publication date
KR940018378A (en) 1994-08-16

Similar Documents

Publication Publication Date Title
EP0274379B1 (en) Process for preparing pyridine-2,3-dicarboxylic acid compounds
JPH0637490B2 (en) Quinolonecarboxylic acid derivative
JPH0826002B2 (en) 1- (2-halogenocyclopropyl) quinolinecarboxylic acid derivative
HU192398B (en) Process for producing derivatives of quinoline-carboxylic acids and pharmaceutical compositions of antibacterial activity containing them
HU187356B (en) Process for producing quinoline-carboxylic acid derivatives
KR0130886B1 (en) Process for preparing fluoro quinoline derivatives
EP0142718B1 (en) Preparation of substituted and unsubstituted 2-((1-carbamoyl-1,2-dimethylpropyl)-carbamoyl)-3-quinolinecarboxylic, nicotinic and benzoic acids
CN100381430C (en) Process for producing substituted alkylamines or salts thereof
EP0937080A1 (en) Method of preparation of physostigmine carbamate derivatives from eseretholes
HU204512B (en) New process for producing quinoline-carboxylic acid derivatives
KR910003617B1 (en) Process for the preparation of quinolene and naphthyridone-carboxylic acids
US5578728A (en) Process for the preparation of a benzo(a)quinolizione derivative
IE41999B1 (en) Preparation of 6,11-dihydro-11-oxodiben(b,e)-oxepin-alkanoic acids
JPH03279348A (en) Production of 2,4,5-trifluoro-3-alkoxybenzoic acid
JPH0635458B2 (en) Pyridonecarboxylic acid derivatives, their esters and their salts
US3840544A (en) Alkyl 4-alkoxy-7-(pyridyl)-3-quinoline-carboxylates,their preparation and conversion to corresponding 4-oxo compounds
KR960011776B1 (en) Process for preparing benzoxazine derivatives
KR100361830B1 (en) Process for preparing alkali metal salts of quinolone carboxylic acid
KR850001698B1 (en) Process for the preparation of 2-dialkylamino-2-phenyl-n-buthyl-3',4',5'-trimethoxybenzoic derivatives
KR900006326B1 (en) Quinoline carboxy acid derivatives and their preparation
KR870001624B1 (en) Process for preparing quinoline derivatives
KR870001004B1 (en) Process for preparing quinolone carboxylic acids
KR900001078B1 (en) A preparation process for cyclo quinolone derivatives
JPH04270272A (en) Production of aminoalkylmorpholine derivative
KR0139261B1 (en) Pyridone carboxylic acid derivatives and process of preparation

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee